{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:57:57Z","timestamp":1791467877132,"version":"4.3.4"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Heart failure (HF) remains a leading cause of morbidity and mortality worldwide, affecting women and men in nearly equal numbers, yet important sex- and gender-related differences remain insufficiently recognized in clinical practice and research. Biological sex and gender influences profoundly the disease development, clinical presentation, diagnosis and management. For decades, most evidence and guideline recommendations have been based on predominantly male cohorts, limiting their applicability to women. This review aims to synthesize the current evidence on sex- and gender-related differences in HF. Also, it integrates data from experimental studies, clinical trials, large registries, and recent guidelines, emphasizing differences in phenotype, biomarker profiles, pharmacologic responses, and access to device-based therapies. Despite better survival, women report greater symptom burden, poorer quality of life, and lower use of optimal medical or device therapy, including lower use of guideline-directed medical therapy and device-based interventions. Pharmacokinetic and pharmacodynamic differences suggest that women may achieve comparable therapeutic benefit at lower medication doses, yet guidelines remain largely sex-neutral. Thus, recognizing these biological and sociocultural distinctions is essential for precision and equity in care, improving diagnostic accuracy, optimizing therapeutic strategies and ensuring equity in cardiovascular care, advancing truly individualized cardiovascular medicine.<\/jats:p>","DOI":"10.3389\/fcvm.2026.1893614","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:10:27Z","timestamp":1785323427000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gender disparities in heart failure diagnosis and management: under the radar"],"prefix":"10.3389","volume":"13","author":[{"given":"Irina","family":"Cabac-Pogorevici","sequence":"first","affiliation":[{"name":"Cardiology Laboratory, \u201cNicolae Testemi\u021banu\u201d State University of Medicine and Pharmacy","place":["Chi\u0219in\u0103u, Republic of Moldova"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuliana","family":"Creang\u0103","sequence":"additional","affiliation":[{"name":"Discipline of Cardiology, \u201cNicolae Testemi\u021banu\u201d State University of Medicine and Pharmacy","place":["Chi\u0219in\u0103u, Republic of Moldova"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inessa","family":"Jitari","sequence":"additional","affiliation":[{"name":"Cardiology Laboratory, \u201cNicolae Testemi\u021banu\u201d State University of Medicine and Pharmacy","place":["Chi\u0219in\u0103u, Republic of Moldova"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Savca","sequence":"additional","affiliation":[{"name":"Cardiology Laboratory, \u201cNicolae Testemi\u021banu\u201d State University of Medicine and Pharmacy","place":["Chi\u0219in\u0103u, Republic of Moldova"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Avram","sequence":"additional","affiliation":[{"name":"Cardiology Laboratory, \u201cNicolae Testemi\u021banu\u201d State University of Medicine and Pharmacy","place":["Chi\u0219in\u0103u, Republic of Moldova"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Corl\u0103teanu","sequence":"additional","affiliation":[{"name":"Discipline of Pneumology and Allergology, \u201cNicolae Testemi\u021banu\u201d State University of Medicine and Pharmacy","place":["Chi\u0219in\u0103u, Republic of Moldova"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriu","family":"Revenco","sequence":"additional","affiliation":[{"name":"Cardiology Laboratory, \u201cNicolae Testemi\u021banu\u201d State University of Medicine and Pharmacy","place":["Chi\u0219in\u0103u, Republic of Moldova"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.36628\/ijhf.2020.0004","article-title":"Sex and gender differences in heart failure","volume":"2","author":"Regitz-Zagrosek","year":"2020","journal-title":"Int J Heart Fail"},{"key":"B2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3904\/kjim.2024.338","article-title":"Sex differences in diagnosis and treatment of heart failure: toward precision medicine","volume":"40","author":"Lee","year":"2025","journal-title":"Korean J Intern Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/eurheartj\/ehv598","article-title":"Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes","volume":"37","author":"Regitz-Zagrosek","year":"2016","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jchf.2019.03.011","article-title":"Sex-based differences in heart failure across the ejection fraction spectrum: phenotyping, and prognostic and therapeutic implications","volume":"7","author":"Stolfo","year":"2019","journal-title":"JACC Heart Fail"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/ejhf.3284","article-title":"Differences in presentation, diagnosis and management of heart failure in women: a scientific statement","volume":"26","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"B6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","article-title":"Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction","volume":"138","author":"Beale","year":"2018","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006539","article-title":"Sex-related differences in heart failure with preserved ejection fraction","volume":"12","author":"Dewan","year":"2019","journal-title":"Circ Heart Fail"},{"key":"B9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/ejhf.67","article-title":"Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"16","author":"Gori","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"B10","doi-asserted-by":"publisher","first-page":"17455057221140209","DOI":"10.1177\/17455057221140209","article-title":"Sex differences in heart failure with preserved ejection fraction: from traditional to sex-specific risk factors","volume":"18","author":"Kaur","year":"2022","journal-title":"Womens Health (Lond)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jacc.2019.05.052","article-title":"Age-related characteristics and outcomes of patients with heart failure with preserved ejection fraction","volume":"74","author":"Tromp","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.20517\/jca.2022.01","article-title":"Mechanisms and implications of sex differences in cardiac aging","volume":"2","author":"Yusifov","year":"2022","journal-title":"J Cardiovasc Aging"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1257335","DOI":"10.3389\/fcvm.2023.1257335","article-title":"Sex differences in mortality and hospitalization in heart failure with preserved and mid-range ejection fraction: a systematic review and meta-analysis of cohort studies","volume":"10","author":"Deng","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/eurjhf\/hfs026","article-title":"Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis","volume":"14","author":"Mart\u00ednez-Sell\u00e9s","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e002883","DOI":"10.1161\/CIRCHEARTFAILURE.115.002883","article-title":"Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women","volume":"9","author":"Eaton","year":"2016","journal-title":"Circ Heart Fail"},{"key":"B16","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jchf.2018.06.002","article-title":"Regional adipose distribution and its relationship to exercise intolerance in older obese patients with heart failure with preserved ejection fraction","volume":"6","author":"Haykowsky","year":"2018","journal-title":"JACC Heart Fail"},{"key":"B17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2024.132478","article-title":"Menopause, epicardial adiposity and preserved ejection fraction heart failure","volume":"11","author":"Museedi","year":"2022","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/CIRCIMAGING.113.000532","article-title":"Relation of regional fat distribution to left ventricular structure and function","volume":"6","author":"Neeland","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"B19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/cvr\/cvy185","article-title":"Sex-specific regulation of collagen I and III expression by 17\u03b2-estradiol in cardiac fibroblasts: role of estrogen receptors","volume":"115","author":"Dworatzek","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/ejhf.1902","article-title":"Characterization of the inflammatory-metabolic phenotype of heart failure with preserved ejection fraction: a hypothesis to explain influence of sex on disease evolution","volume":"22","author":"Packer","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B21","first-page":"34","article-title":"Women, men and heart failure: a review","volume":"6","author":"Rosengren","year":"2008","journal-title":"Heart Fail Monit"},{"key":"B22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/14017431.2020.1792972","article-title":"Clinical presentation and outcomes in women and men with advanced heart failure","volume":"54","author":"Vishram-Nielsen","year":"2020","journal-title":"Scand Cardiovasc J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/1354750X.2022.2122299","article-title":"Sex differences in heart failure: the evolving use of biomarkers","volume":"28","author":"Blumer","year":"2023","journal-title":"Biomarkers"},{"key":"B24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10741-022-10279-2","article-title":"Sex-related differences in contemporary biomarkers for heart failure: a review","volume":"28","author":"Suthahar","year":"2023","journal-title":"Heart Fail Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"925872","DOI":"10.3389\/fcvm.2022.925872","article-title":"Sex differences in ischemic heart disease and heart failure biomarkers","volume":"9","author":"Sobhani","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1002\/ejhf.2005","article-title":"Sex-based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril\/valsartan","volume":"8","author":"Ibrahim","year":"2021","journal-title":"ESC Heart Fail"},{"key":"B27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cjca.2018.01.019","article-title":"Sex differences in left ventricular cavity dilation and outcomes in acute heart failure patients with left ventricular systolic dysfunction","volume":"34","author":"Kajimoto","year":"2018","journal-title":"Can J Cardiol"},{"key":"B28","first-page":"603","article-title":"Prognostic value of anxiety between heart failure with reduced ejection fraction and heart failure with preserved ejection fraction","volume":"83","author":"Lin","year":"2021","journal-title":"Psychosom Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/ehf2.15059","article-title":"Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides","volume":"12","author":"Berthelot","year":"2025","journal-title":"ESC Heart Failure"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/S0140-6736(19)31792-1","article-title":"Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study","volume":"394","author":"Santema","year":"2019","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11897-023-00638-6","article-title":"Implications of sex differences on the treatment effectiveness in heart failure with reduced ejection fraction related to clinical endpoints and quality of life","volume":"21","author":"Aydin","year":"2024","journal-title":"Curr Heart Fail Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jchf.2019.01.009","article-title":"Adverse drug reactions to guideline-recommended heart failure drugs in women: a systematic review","volume":"7","author":"Bots","year":"2019","journal-title":"JACC Heart Fail"},{"key":"B33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jchf.2019.01.003","article-title":"Sex differences in outcomes and responses to spironolactone in heart failure with preserved ejection fraction: a secondary analysis of TOPCAT trial","volume":"7","author":"Merrill","year":"2019","journal-title":"JACC Heart Fail"},{"key":"B34","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ijcha.2022.101075","article-title":"Inequality between women and men in ICD implantation","volume":"24","author":"Ingelaere","year":"2022","journal-title":"Europace"},{"key":"B35","first-page":"1579","article-title":"Underrepresentation of women in implantable cardioverter-defibrillator trials","volume":"18","author":"Han","year":"2021","journal-title":"Heart Rhythm"},{"key":"B36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.hfc.2018.08.002","article-title":"Heart failure with preserved ejection fraction in women","volume":"15","author":"Tibrewala","year":"2019","journal-title":"Heart Fail Clin"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jamacardio.2020.3152","article-title":"Diagnosis of heart failure with preserved ejection fraction among patients with unexplained dyspnea","volume":"5","year":"2020","journal-title":"JAMA Cardiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11897-020-00487-7","article-title":"Sex differences in cardiovascular aging and heart failure","volume":"17","author":"Oneglia","year":"2020","journal-title":"Curr Heart Fail Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/eurheartj\/ehae868","article-title":"Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years","volume":"46","author":"van Essen","year":"2025","journal-title":"Eur Heart J"}],"updated-by":[{"DOI":"10.3389\/fcvm.2026.1973162","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000}},{"DOI":"10.3389\/fcvm.2026.1998092","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000}}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1893614\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:13:31Z","timestamp":1791465211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1893614\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":39,"alternative-id":["10.3389\/fcvm.2026.1893614"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1893614","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"1893614"}}